INTRODUCTION:

C

o

s

m

a

s

 

i

s

a

p

r

o

f

e

s

s

i

o

n

a

l

l

y

m

a

n

a

g

e

d

g

r

o

u

p

o

f

c

o

m

p

a

n

i

e

s

c

a

m

e

i

n

t

o

e

x

i

s

t

e

n

c

e

i

n

t

h

e

y

e

a

r

 

1

9

9

4

A

b

r

a

i

n

-

c

h

i

l

d

u

p

s

h

o

t

o

f

a

q

u

a

l

i

f

i

e

d

P

h

a

r

m

a

c

i

s

t

M

r

.

P

u

n

i

t

J

a

i

n

,

T

h

e

C

h

i

e

f

M

a

n

a

g

i

n

g

D

i

r

e

c

t

o

r

,

b

a

c

k

e

d

w

i

t

h

t

h

e

g

r

a

n

d

M

o

r

a

l

s

u

p

p

o

r

t

o

f

h

i

s

e

n

t

i

r

e

J

a

i

n

f

a

m

i

l

y

,

h

i

s

B

r

o

t

h

e

r

s

,

M

r

.

S

a

n

j

a

y

J

a

i

n

,

M

r

.

M

a

n

u

J

a

i

n

a

n

d

M

r

.

T

a

n

u

j

J

a

i

n

A

n

u

p

c

o

m

i

n

g

R

e

s

e

a

r

c

h

b

a

s

e

d

I

n

d

i

a

n

P

h

a

r

m

a

c

e

u

t

i

c

a

l

C

o

m

p

a

n

y

,

I

n

v

o

l

v

e

d

i

n

m

a

n

u

f

a

c

t

u

r

i

n

g

o

f

P

h

a

r

m

a

c

e

u

t

i

c

a

l

p

r

o

d

u

c

t

s

,

m

a

i

n

l

y

i

n

t

o

c

o

n

t

r

a

c

t

m

a

n

u

f

a

c

t

u

r

i

n

g

Mission:

“Customer care is the integral part of our job function”

VISION

To focus on building & enhancing

manufacturing capabilities in order

to be the preferred choice for

contract manufacturing of

pharmaceutical formulations

Milestones:

1995-COSMAS has establish with a tiny manufacturing facility at Ludhiana, Industrial Hub of Punjab.

1996-Market penetration as new entrant with the concept of “Third party manufacturing”

2002-Launched Cepham antibiotics division with a launch of latest molecules like Cefixime and Cefpodoxime Proxetil

2004-Introduced the latest technology of drug packaging using Alu-Alu technique, first of its kind in northern India

2005-Business Expansion with an Ultra-modern Drugs Formulation medium sized unit at BADDI in the state of Himachal Pardesh.

2006-Entered into new drugs molecules by getting around 30 New Drugs Approvals from DCGI

2008-Established a well-knit distribution network in Bulk Drugs

2011-Established USFDA & UK MHRA Compliance Plant with the name of “Cosmas Research Lab Ltd.” .

Directors : Mr. PUNIT JAIN CHIEF MANAGING DIRECTOR

Mr. SANJAY JAIN DIRECTOR TECHNICAL

Mr. MANU JAIN DIRECTOR COMMERCIAL

Mr. TANUJ JAIN DIRECTOR MARKETING

The Directors have an extraordinary track record of success in Pharma Industry, and they have together grown the business from a small formulation unit to a giant formulation facility catering to major Pharma players of the country.

Dr. TILAK RAJ BHARDWAJ INDEPENDENT DIRECTOR

Dr. TAPAN KUMAR PAL INDEPENDENT DIRECTOR

Mr. RAM RATAN GARG INDEPENDENT DIRECTOR

Mr. PRAKASH CHOPRA INDEPENDENT DIRECTOR

Dr. Tilak & Dr. Tapan has got more than 30 year of experience in Research & Development and our working in major Research institute of the country.Mr. Ram Ratan Garg is a Charted Accountant.Mr. Prakesh Chopra is an IT specialist.

IndependentDirectors :

Cosmas’s Employee Database is an integration of

highly Specialized, Qualified & Experienced

personnel having both technical and non-technical

backgrounds.

Presently the group has a total workforce of 610

professionals out of which 300 make for Senior /

Middle / Lower management and 310

for Skilled Workers.

B Pharma/M Pharma 45%

Graduates20%

M.Sc10%

MBA25%

B Pharma/M Pharma Graduates M.Sc

MBA

Employee Strength :

Baddi

Excise & Tax Free Zone

Cosmas manufacturing facility is strategically located at Baddi (

H.P.), enabling it to offer maximum cost advantage to the customers.

Plant 1

COSMAS RESEARCH LAB LTD has started operation in a stat of art manufacturing facility at industrial town Ludhiana in state of Punjab. The facility has cephalosporin & Oncology blocks with “Latest European Machinery” which are UK-MHRA & USFDA approvable facility .

COSMAS RESEARCH

LAB LTD.

COSMAS RESEARCH

LAB LTD.

• Thiocolchicoside 4 mg/8 mg + Aceclofenac 50 mg/100 mg Tabs.• Thiocolchicoside 4 mg/8 mg + Etodolac 300 /400mg Tabs.• Thiocolchicoside 4 mg/8 mg + Lornoxicam 4 mg/8 mg Tabs.• Gemifloxacin 320 mg + Ambroxol 75 mg (SR) Tabs.• Pregabalin 75 mg/150 mg + Methylcobalamin 750 mcg + Benfothiamine 7.5 mg + Pyridoxine 1.5 mg + Folic Acid 0.75 mg Caps.• Rosuvastatin 5 mg/10 mg/20 mg + Fenofibrate 80 mg/160 mg Tabs.• Cefixime 100 mg/200 mg + Ofloxacin 100 mg/200 mg Tabs.• Cefixime 200 mg / Dicloxacillin Sodium 500 mg (ER) Tabs.• Artesunate 50 mg/100 mg/200 mg+ Sulphadoxine 500 mg + Pyrimethamine 25 mg

Tabs. (Kit)• Prasugen HCl 5 mg/10 mg Tabs.• Pregabalin 300 mg (SR) + Methylcobalamin 1500 mcg Tabs.• Rupatadine 10 mg + Montelukast Sodium 10 mg Tabs.• Atorvastatin Calcium 10 mg + Glimepiride 2 mg + Meformin HCl 500 mg (SR) Tabs.• Aceclofenac 200 mg + Tizanidine 2 mg Tabs.

Key Drivers of Growth : LARGE NUMBER OF DCGI APPROVALS FOR

COSMAS PHARMACLS LTD.

DCGI APPROVALS FOR COSMAS RESEARCH LAB LTD.

Key Drivers of Growth :

• Cefixime 200 mg + Clavulanic Acid 125 mg Tabs.

• Cefixime 50 mg + Potassium Clavulanate 31.25 mg Tab. /Syp.

• Cefixime 200 mg + Dicloxacillin Sodium 500 mg. (SR) Tab.

• Cefixime 100 mg + Ofloxacin 100 mg Tab.

• Cefixime 200 mg + Ofloxacin 200 mg Tab.

• Cefixime SR 400 mg + Moxifloxacin SR 400 mg Tab.

• Cefpodoxime Proxetil 100mg. + Potassium Clavulanate 62.5mg

Tab.

• Cefpodoxime Proxetil 200mg. + Potassium Clavulanate 125 mg

Tab.

• Cefpodoxime Proxetil 50mg. + Potassium

Clavulanate31.25(DrySyp.)

Production Capacity of CRLL Plant

• Cephalosporin :

- 10 Lac tablets per shift.- 4 Lac Capsules per shift.- 50,000 vials of Dry Syrup

per shift.- 2 Lac Vials of Injection per

shift. 

Oncology :

- Facility is designed strictly as per USFDA norms, compatible to OEL level 5.

- All the machinery is been imported from IMA Life (Italy) which are CFR-21, part 11 compliant.

Expanding Capacity and Widening the Product Portfolio :

• Cephalosporins Block is spread over 2720 sq. meter and is equipped with latest world class machinery.

• Dehumidification system imported from Munters, Sweden.

• Automatic powder transfer system in OSD in a closed loop.

• Injectable lines imported from Macofar Italy with RABS technology.

• Water system completely fitted with “zero dead lag valves” of GEMU, Germany to avoid any microbial growth.

• Plant specially designed at Low RH & Low temprature, most suitable for clavulanic acid preparation.

Cephalosporin

COSMAS RESEARCH LAB LTD

COSMAS RESEARCH LAB LTD

Research & Development

Research & Development:

• Cosmas is a R&D driven pharmaceuticals company, striving for new product developments and innovations.

• Extensive F & D and Product Development activities are carried out in house and clinical trials and bioequelence studies are carried out with help of reputed research centre like IFS College, Moga; University of Jhadhavpur, Kolkata and Bombay Research Centre, Mumbai.

• The company has modular laboratories with latest sophisticated instruments like UPLC.

• The company has in house stability studies, comprehensive SOP’s and process validation system in place.

• Oriented R&D environment to focus on commercially viable development.

CRLL Equipment

& Machinery:

• We are looking for channel partners all over the world especially

Latin America, U.S, European, CIS countries. Also for foreign

companies who want to get their products manufactured by a

Third Party manufacturer, and market it Internationally.

Export:

In Summary A strong performance on all parameters

Buoyant performance across key geographies

Continuing focus on cost optimization

Robust product flow

R & D pipeline progressing well

Growth

THANK YOU